AMBICA AGARBATHIES & AROMA IND Overview
Ambica Agarbathies Aroma & Industries Limited is a promoter-controlled, Andhra Pradesh-based micro-cap that combines a legacy regional fast-moving consumer goods franchise — the "Ambica" incense-stick (agarbathi) brand, with roots going back to 1946 — with a small hospitality portfolio anchored by the 86-room Ambica Empire hotel in Vadapalani, Chennai and a smaller property in Visakhapatnam. Agarbathies generate roughly 77% of total income and hotels roughly 23% (FY2026). The brand is strongest in Andhra Pradesh, Telangana and Tamil Nadu, where ICRA has previously described it as well established. The company is capital-heavy for its size (fixed assets of about INR 128 Cr against revenue of INR 141 Cr), lightly profitable (FY2026 PAT INR 3.45 Cr), leverage-dependent (borrowings about INR 96 Cr) and pays no dividend. It trades at roughly 0.37–0.38x book value, reflecting low returns on equity, tight interest cover and family-dominated governance, set against a substantial hard-asset base.
The company's own description (AR FY2025-26, MD&A)
The company describes itself as a manufacturer and seller of incense sticks in India that also operates hotels in Chennai and Visakhapatnam and is involved in film production and distribution, founded in 1946 and based in Eluru, West Godavari district, Andhra Pradesh. It reports two operating segments — the Agarbathies Division and the Hotel Division — although the MD&A text refers to "three segments" before listing only two (an internal drafting inconsistency).
The MD&A frames agarbathi demand around India's position as one of the largest producers, regional consumption (South India estimated at 35% of domestic sales, West 30%, North 18%, East 17%), and a rural skew (about 61% of domestic consumption). It also states that "about 90 foreign countries" use its agarbathies — a claim that sits uneasily with the same report's disclosure of NIL foreign exchange earnings in FY2026.
Independent characterisation
Ambica is best understood as a regional, family-run branded incense manufacturer bolted onto a hotel real-estate holding. The two businesses share no operating synergy; they share a promoter family, a balance sheet and a lender base.
Agarbathies (product revenue): Manufacturing and sale of branded incense sticks, herbal sticks and dhoop through a distributor/stockist network (the Directors' Report thanks "stockiest and distributors"). Revenue is pure product sales; no subscription, licensing or recurring contract revenue. Customers are trade intermediaries (distributors, wholesalers, retailers) serving end-consumers who use incense for religious and household purposes. The company sits in the conversion/branding stage of the value chain: it buys raw agarbathi inputs (bamboo sticks, charcoal/wood powder, perfumery compounds), processes and perfumes them, packs and brands them. Related-party filings also show purchase and sale of "Darbar Agarbathies" with ACP Industries Limited, indicating some traded/outsourced volume.
Hotels (service revenue): Room, food and beverage, banqueting and conference revenue from the Ambica Empire (Chennai) and a Visakhapatnam hotel. Customer types include business travellers, medical tourists (the Chennai property is near several major hospitals), pilgrims (the Vadapalani Murugan temple is a short walk away), wedding and MICE (meetings, incentives, conferences, exhibitions) clients.
Ancillary/legacy activities: Farmland with a resort club house and health centre; wind power generation; film production (three feature films) and film distribution (over 500 films distributed historically). None is reported as a separate segment and their current scale is not publicly disclosed.
Revenue model mix (FY2026)
| Revenue type | Source | Approx. share of total income FY2026 |
|---|---|---|
| Product (agarbathi) sales | Agarbathies Division | 77.5% |
| Services (hospitality) | Hotel Division | 22.5% |
| Subscription | — | 0% |
| Licensing | None disclosed | 0% |
Basis: Segment turnover of INR 11,583.75 lakh (agarbathies) and INR 3,370.27 lakh (hotels) against total income of INR 14,954.02 lakh, AR FY2025-26. Segment figures sum exactly to total income (including other income of INR 845.76 lakh), so other income appears to be allocated within segments.
End-markets
| End-market | Description | Geography |
|---|---|---|
| Religious / household incense | Daily puja, festivals, temples | Primarily Andhra Pradesh, Telangana, Tamil Nadu |
| Business & medical travel lodging | Mid-scale/upscale city hotel rooms | Chennai (Vadapalani) |
| Leisure / coastal tourism | Smaller hotel | Visakhapatnam |
| MICE & weddings | Banquet halls, conference rooms | Chennai, Visakhapatnam |
Strategy
Stated strategy (themes from AR FY2025-26)
The company does not publish a formal strategy document, investor presentation or medium-term plan. Strategic themes extractable from the annual report are:
-
Profit retention for business reinvestment: The board declined a dividend because profits are "planned to be ploughed back into the business operations."
-
Overseas expansion (aspirational): The company "plans to explore and tap overseas markets" and to launch new products first domestically and then overseas.
-
Hospitality positioning: The MD&A describes a hotel brand "built on service excellence, guest experience, and operational efficiency," targeting business travellers, tourists and event clients, and cites domestic leisure, spiritual tourism, MICE and destination weddings as demand drivers for FY2026.
-
Scalable processes: The HR section refers to building "robust platforms" and "scalable processes" to support growth (generic language; no specifics).
Announced initiatives (last 24 months)
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Preferential issue to promoter group | Approved by board 30 May 2026; EGM 30 Jun 2026 | Up to 8,48,600 shares at INR 25 (INR 10 face + INR 15 premium) raising INR 2.12 Cr for working capital | Allotment evidenced by Sep 2026 shareholding (promoters 46.08%) |
| CMD continuity | Feb 2026 | Three-year extension of founder-family CMD | Approved |
| Hotel refurbishment | 2023 (outside window but relevant) | Ambica Empire renovated per booking platforms | Completed |
| Capex | FY2025 | ~INR 8 Cr capex (derived); purpose not disclosed | Completed |
Sustainability, cost programmes and guidance
ESG commitments: None announced.
Cost programmes: Only generic energy-control statements; no quantified programme.
Medium-term financial targets / guidance: None published.
Products & Services
Agarbathies Division
| Product / brand | Description | Target customer | Launch year | Pricing model | Source |
|---|---|---|---|---|---|
| Ambica Durbar Bathi | Flagship incense stick, multiple fragrances, natural base materials | Mass household / religious users | Not disclosed (legacy) | MRP retail packs via distributors; prices not disclosed | AR FY2025-26 |
| Amrutham (Herbal Bathies) | Herbal incense sticks, multiple fragrances | Users seeking herbal / natural incense | — | Retail packs | AR FY2025-26 |
| Athjisaya Dhoop | Dhoop (stickless/charcoal-free incense) in multiple fragrances | Religious users, dhoop segment | — | Retail packs | AR FY2025-26 |
| Ambica Baba Harathi | Herbal agarbathi sub-brand | Religious users | — | — | Sugandh India |
| Ambica Gowpuja | Herbal agarbathi sub-brand | Religious users | — | — | Sugandh India |
| Ambica Bangaram | Herbal agarbathi sub-brand | Religious users | — | — | Sugandh India |
| Ambica Heaven | Herbal agarbathi sub-brand | Religious users | — | — | Sugandh India |
| Fragrance range | Gulab/rose, strawberry, spicy, sandal, rosemary, oriental, opium, myrrh, lavender, jasmine, among others | All | Ongoing | — | Wright Research |
| Cones and natural incense | Incense cones and natural incense variants | All | — | — | TradingView profile |
A family director (Ambica Ramanjaneyulu, a former president of the All India Agarbatti Manufacturers Association) has stated publicly that the family has developed 20–25 herbal agarbathi brands. Not all are confirmed as sold by the listed entity versus related family companies.
Specifications: The company's generic product description notes burning times for agarbathies ranging from 15 minutes to 3 hours depending on size and quality. Product-level specifications are not otherwise disclosed.
Hotel Division
| Property | Location | Key specifications | Facilities | Year | Source |
|---|---|---|---|---|---|
| Ambica Empire | 79 (also cited as 57), 100 Feet Road, Vadapalani, Chennai 600026 | 84–86 rooms incl. 5 suites; 7 floors; 3–4 star classification | 4 conference/banquet halls (His Highness ~1,800 sq ft, Her Majesty ~800 sq ft, Citrus I and II / Citrus Hall); restaurants Royal Palate, Green Chillies, Andhra Samskruti; pub, gym, spa, steam room | Built 1999; renovated 2023 | Hotel directories; Upstox; Wright Research |
| Hotel Ambica Sea Green | Plot 1, Kirlampudi Layout, Visakhapatnam 530017 | 33 rooms per directory listing (40 rooms per family interview); 6 floors | 4 meeting rooms, capacity ~250 | — | Successful Meetings; Sugandh India |
Indicative historic published rack rates for Ambica Empire (third-party directory, undated): standard rooms USD 43–53, suites USD 78–83. Current tariffs not disclosed.
Other activities
| Activity | Description | Status |
|---|---|---|
| Film production | Three feature films produced | Historic; current activity not disclosed |
| Film distribution | 500+ films distributed | Historic; current activity not disclosed |
| Wind power | Wind power generation | Capacity and revenue not disclosed |
| Farmland resort | Farmland with resort club house and health centre | Revenue not disclosed |
Financial Narrative
All figures standalone (the company has no subsidiaries as of FY2026). FY2024–FY2026 income-statement lines are summed from reported quarterly results (two decimals); FY2022–FY2023 are annual figures rounded to whole crore by Screener.in from BSE filings. FY2026 and FY2025 headline numbers reconcile to the AR FY2025-26 Directors' Report.
Income statement (INR Cr)
Notes: Gross profit (revenue less cost of materials) is not publicly disclosed in extractable form and is omitted. Operating income (EBIT) is shown via EBITDA less depreciation. FY2022 tax shown as a credit (Screener reports a tax rate of minus 300%). Net income FY2022–FY2023 derived from EPS × 1.7177 Cr shares. Diluted EPS equals basic: no convertible instruments outstanding (AR FY2025-26). The AR FY2025-26 Directors' Report narrative describes FY2025 as a "Loss of Rs. 48.86 Lakhs", contradicting its own table (profit of INR 48.86 lakh) and the quarterly filings; the table is treated as correct.
Margins and growth
Revenue CAGR FY2022–FY2026: approximately 5.0% (INR 116 Cr to INR 141.08 Cr over four years). Longer-term, Screener reports 10-year sales CAGR of 3% and 5-year CAGR of 0% — revenue in FY2026 remains below the FY2020 peak of INR 168 Cr.
Commentary. The P&L tells a story of a business that has not regained its pre-COVID scale. Revenue collapsed from INR 168 Cr (FY2020) to INR 116 Cr (FY2022), stagnated, then fell again to INR 98 Cr in FY2024 before recovering 26% in FY2025 and 14% in FY2026, driven almost entirely by agarbathies (+20% in FY2026) rather than hotels (+4%). The FY2026 recovery was concentrated in an exceptional December 2025 quarter (revenue INR 54.04 Cr, the highest quarter in the series), likely reflecting festive-season and/or bulk trade sales; the March 2026 quarter then fell back to INR 22.27 Cr.
Operating margins are thin and volatile (3.9%–12.1%), consistent with a commoditised regional incense business exposed to raw-material (perfumery compounds, bamboo, charcoal) cost swings. The most important structural feature is that finance costs (INR 11.27 Cr in FY2026) consume more than the entire EBITDA (INR 10.17 Cr); the company is profitable at the pre-tax line only because of other income (INR 8.46 Cr in FY2026, 168% of PBT). The composition of other income is not detailed in reviewed excerpts (likely rental, interest and miscellaneous income); its sustainability is a key analytical question. The effective tax rate is erratic due to deferred tax movements.
Quarterly trend (INR Cr)
Source: Screener.in compilation of quarterly results filed with BSE/NSE.
Q1 FY2027 (June 2026 quarter) revenue declined 18% YoY to INR 24.65 Cr, but EBITDA margin expanded to 12.8% and net profit was broadly flat at INR 1.11 Cr. Trailing-twelve-month (Q2FY26–Q1FY27) revenue is about INR 136 Cr and PAT about INR 3.42 Cr.
Balance sheet (INR Cr, as at 31 March)
Goodwill is presumed nil (no acquisitions). Zerodha's net debt figures imply cash/near-cash of roughly INR 8–10 Cr. Book value per share is computed on 1.7177 Cr shares; third-party sources report slightly different BVPS values due to timing.
Commentary. Borrowings rose 50% in two years (INR 64 Cr in FY2022 to INR 96 Cr in FY2026) even as equity grew only about 11%, pushing debt/equity from 0.63x to 0.85x. The FY2025 increase funded roughly INR 8 Cr of capex (fixed assets up INR 10 Cr, likely hotel refurbishment and/or plant). The FY2026 increase coincided with a INR 21 Cr jump in "other assets" — i.e., working capital build (debtor days rose from 42 to 61) — not productive capex. The asset base is dominated by fixed assets (52% of total assets), principally the hotel properties, which give the equity a tangible-asset underpinning but deliver low returns.
Cash flow (INR Cr)
Source: Screener.in from filed cash flow statements; capex derived as CFO minus FCF.
Commentary. Cash conversion has deteriorated sharply: operating cash flow declined every year from INR 16 Cr (FY2022) to negative INR 7 Cr (FY2026), even as reported profits improved. The FY2026 revenue growth was therefore bought with receivables and working capital, financed by debt. Two consecutive years of negative free cash flow, combined with rising borrowings and a promoter preferential issue of only INR 2.12 Cr explicitly "for working capital", point to a tight liquidity position.
Ratios
ROCE, debtor/inventory/payable days, CCC and working capital days from Screener.in; other ratios computed from tables above.
Commentary. Returns are structurally sub-par: five-year ROE averages about 1% against a cost of equity that for an Indian micro-cap would plausibly exceed 14%. Interest coverage has hovered between 0.8x and 1.5x — dangerously thin — and net debt/EBITDA of 8.7x (FY2026) would normally signal stress. The rise in debtor days to 61 in FY2026 is the most important near-term red flag in the working capital profile.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products / services |
|---|---|---|
Agarbathies Division | Manufacturing and trading of incense products | Durbar Bathi, Amrutham (herbal bathies), Athjisaya Dhoop; other Ambica sub-brands |
Hotel Division | Owned hotel operations | Ambica Empire (Chennai); Visakhapatnam hotel (Ambica Sea Green); rooms, F&B, banqueting |
Revenue by Segment
| Segment | FY2025 | FY2026 |
|---|---|---|
Agarbathies Division turnover (INR Cr) | 96.59 | 115.84 |
Hotel Division turnover (INR Cr) | 32.33 | 33.70 |
Total income (INR Cr) | 128.92 | 149.54 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (%) and Segment Margins & Growth (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Agarbathies share of total income (%) | 74.9 | 77.5 |
Hotel share of total income (%) | 25.1 | 22.5 |
Agarbathies YoY growth (%) | — | 19.9 |
Hotel YoY growth (%) | — | 4.2 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 116 | 117 | 97.84 | 123.62 | 141.08 |
Total expenses excl. interest & depreciation (INR Cr) | 102 | 109 | 94.05 | 113.39 | 130.91 |
EBITDA excl. other income (INR Cr) | 14 | 8 | 3.79 | 10.23 | 10.17 |
Other income (INR Cr) | 1 | 5 | 5.35 | 5.31 | 8.46 |
Interest / finance cost (INR Cr) | 12 | 9 | 9.71 | 10.86 | 11.27 |
Depreciation (INR Cr) | 3 | 2 | 1.69 | 1.99 | 2.33 |
Profit before tax (INR Cr) | 1 | 3 | -2.26 | 2.69 | 5.03 |
Tax (INR Cr) | -1.4 | 0.5 | 1.40 | 2.20 | 1.58 |
Net income (INR Cr) | 2.40 | 2.53 | -3.66 | 0.49 | 3.45 |
EPS basic (INR) | 1.40 | 1.47 | -2.13 | 0.29 | 2.01 |
EPS diluted (INR) | 1.40 | 1.47 | -2.13 | 0.29 | 2.01 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
EBITDA margin (%) | 12.1 | 6.8 | 3.9 | 8.3 | 7.2 |
Operating (EBIT) margin excl. other income (%) | 9.5 | 5.1 | 2.2 | 6.7 | 5.6 |
Pre-tax margin (%) | 0.9 | 2.6 | -2.3 | 2.2 | 3.6 |
Net margin (%) | 2.1 | 2.2 | -3.7 | 0.4 | 2.4 |
Revenue growth YoY (%) | -18.9 | 0.9 | -16.4 | 26.3 | 14.1 |
Effective tax rate (%) | -300 | 17 | -62 | 81.9 | 31.5 |
Income Statement and Margin Analysis (%)
| Metric | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|---|---|---|
Revenue (INR Cr) | 23.01 | 33.51 | 36.05 | 31.05 | 30.14 | 34.63 | 54.04 | 22.27 | 24.65 |
EBITDA (INR Cr) | 3.52 | 3.09 | 2.35 | 1.27 | 3.09 | 1.83 | 3.28 | 1.97 | 3.16 |
EBITDA margin (%) | 15.30 | 9.22 | 6.52 | 4.09 | 10.25 | 5.28 | 6.07 | 8.85 | 12.82 |
Other income (INR Cr) | 1.05 | 1.42 | 1.51 | 1.33 | 1.74 | 2.14 | 1.19 | 3.39 | 1.98 |
Interest (INR Cr) | 2.65 | 2.84 | 2.93 | 2.44 | 2.72 | 2.32 | 3.07 | 3.16 | 3.00 |
PBT (INR Cr) | 1.50 | 1.25 | 0.51 | -0.57 | 1.52 | 1.24 | 0.90 | 1.37 | 1.47 |
Net profit (INR Cr) | 1.12 | 0.93 | 0.38 | -1.94 | 1.14 | 0.93 | 0.56 | 0.82 | 1.11 |
EPS (INR) | 0.65 | 0.54 | 0.22 | -1.13 | 0.66 | 0.54 | 0.33 | 0.48 | 0.65 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 219 | 204 | 211 | 224 | 245 |
Net fixed assets (INR Cr) | 122 | 122 | 120 | 130 | 128 |
Capital work in progress (INR Cr) | 0 | 0 | 3 | 0 | 0 |
Investments (INR Cr) | 8 | 8 | 9 | 10 | 12 |
Other assets incl. working capital & cash (INR Cr) | 90 | 74 | 79 | 84 | 105 |
Total borrowings (INR Cr) | 64 | 63 | 67 | 82 | 96 |
Other liabilities (INR Cr) | 53 | 36 | 43 | 32 | 36 |
Share capital (INR Cr) | 17.18 | 17.18 | 17.18 | 17.18 | 17.18 |
Reserves (INR Cr) | 85 | 88 | 84 | 92 | 96 |
Shareholders' equity (INR Cr) | 102 | 105 | 101 | 109 | 113 |
Book value per share (INR) | 59.6 | 61.1 | 58.8 | 63.6 | 65.6 |
Net debt per Zerodha (INR Cr) | — | — | — | 71.97 | 88.17 |
Cash Flow and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (INR Cr) | 16 | 8 | 5 | 1 | -7 |
Investing cash flow (INR Cr) | 0 | -2 | 2 | -5 | 6 |
Financing cash flow (INR Cr) | -17 | -7 | -6 | 3 | -1 |
Capex (INR Cr, derived) | 0 | 2 | 3 | 8 | 0 |
Free cash flow (INR Cr) | 16 | 6 | 2 | -7 | -7 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
CFO / EBITDA (%) | 112 | 101 | 91 | 14 | -66 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) | 2.4 | 2.4 | -3.6 | 0.4 | 3.1 |
ROA (%) | 1.1 | 1.2 | -1.7 | 0.2 | 1.4 |
ROCE (%) | 7 | 7 | 5 | 7 | 8 |
Debt / equity (x) | 0.63 | 0.60 | 0.66 | 0.75 | 0.85 |
Net debt / EBITDA (x) | — | — | — | 7.0 | 8.7 |
Interest coverage, EBIT incl. other income / interest (x) | 1.08 | 1.33 | 0.77 | 1.25 | 1.45 |
Asset turnover (x) | 0.53 | 0.57 | 0.46 | 0.55 | 0.58 |
Debtor days | 91 | 60 | 35 | 42 | 61 |
Inventory days | 57 | 10 | 30 | 22 | 20 |
Payable days | 108 | 17 | 71 | 15 | 18 |
Cash conversion cycle (days) | 40 | 53 | -6 | 49 | 63 |
Working capital days | 111 | 162 | 197 | 144 | 161 |
Region Overview
| Region | FY2026 |
|---|---|
Domestic (India) revenue from operations (INR Cr) | 141.08 |
Export revenue — foreign exchange earnings (INR Cr) | 0 |
Segment Overview — Agarbathies
| Segment | Andhra Pradesh / Telangana | Tamil Nadu | Rest of India | Overseas |
|---|---|---|---|---|
Agarbathies | Core market (ICRA: brand well established) | Established market (ICRA) | Distribution extent not disclosed | Company claims product used in ~90 countries; no direct export revenue booked in FY2026 |
Hotels | Visakhapatnam property | Chennai (Ambica Empire) | — | — |
Capital Markets
| Measure | Value | Source |
|---|---|---|
Price (19 Oct 2026) | INR 25.2 | Screener.in |
52-week range | INR 20.0 – 29.9 | Screener.in |
1-year return | -4% | Screener.in (stock price CAGR) |
3-year price CAGR | -13% | Screener.in |
5-year price CAGR | +5% | Screener.in |
YoY change at 26 May 2026 | -22.85% | Upstox |
Price reference (INR) | May 2025 | Nov 2024 |
Share price (INR) | 27.22 | 30.64 |
Valuation Multiples
| Multiple | Ambica (Oct 2026) | Notes |
|---|---|---|
P/E (TTM) | 12.7x | Screener.in; earlier readings ranged from ~11.6x (Wright, Sep 2026) to 85.5x (Zerodha, on FY2025 earnings) |
P/B | 0.37–0.38x | Screener.in (BV INR 65.6) |
EV/EBITDA | ~11.9x (FY2025 basis, Zerodha); ~13x FY2026 basis (derived: INR 43.3 Cr mcap + INR 88.17 Cr net debt ÷ INR 10.17 Cr EBITDA) | Derived figure indicative |
EV/Sales | ~0.93x (derived: INR 131.5 Cr EV ÷ INR 141.08 Cr) | Derived |
Market cap / sales | ~0.31x | Derived |
Capital Markets (Annual)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Dividend payout (%) | 0 | 0 | 0 | 0 | 0 |
Credit Ratings
| Agency | Rating | Date | Status |
|---|---|---|---|
ICRA | [ICRA]B (long-term, INR 66 Cr fund-based facilities) | 24 Oct 2018 | Assigned |
ICRA | [ICRA]B (Stable); Withdrawn | 16 Nov 2018 | Withdrawn |
Moody's / S&P / Fitch | Not rated | — | — |
Current | AR FY2025-26 lists credit ratings obtained during the year as "NA" | FY2026 | Unrated |
Key Events
| Event | Shares | Price (INR) | Proceeds (INR Cr) |
|---|---|---|---|
Shares outstanding 31 Mar 2026 | 17,177,400 | — | — |
Preferential allotment to promoter group (2026) | 848,600 | 25 | 2.12 |
Post-allotment shares (derived) | 18,026,000 | — | — |
Analyst Conclusions
Management guidance
None. Management provides no numeric guidance. Qualitative commentary expects good hotel business in coming years and aims to expand overseas and launch new products.
Consensus expectations
None (no analyst coverage).
Bull case
-
Asset-backed deep value: At ~0.37x book value with INR 128 Cr of fixed assets (largely owned urban hotel real estate), the market capitalisation of ~INR 43–45 Cr is a fraction of the asset base; any asset monetisation or re-rating could unlock material value.
-
Earnings inflection: PAT recovered from a INR 3.66 Cr loss (FY2024) to INR 3.45 Cr (FY2026), and Q1 FY2027 EBITDA margin reached 12.8% — if margins sustain at 10%+ on INR 140 Cr revenue, EBITDA would rise meaningfully above interest cost.
-
Promoter alignment: The 2026 preferential allotment lifted promoter holding to 46.08%, reversing the decline from 48.35% (FY2023) and signalling confidence at INR 25/share.
Bear case
-
Interest consumes operating profit: FY2026 finance cost (INR 11.27 Cr) exceeded EBITDA (INR 10.17 Cr); profits depend on other income whose sustainability is opaque.
-
Cash burn and leverage creep: Operating cash flow turned negative (minus INR 7 Cr) as debtor days jumped to 61 and borrowings rose to INR 96 Cr; the INR 2.12 Cr equity infusion is small relative to this gap.
-
Structural under-performance: Ten-year sales CAGR of 3%, five-year ROE of ~1%, no R&D and family-concentrated governance suggest the business has struggled to compound value despite its brand heritage.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
| Q2 FY2027 results | Nov 2026 | Revenue recovery after -18% Q1; debtor days; interest cost |
| Q3 FY2027 (festive quarter) | Feb 2027 | Whether Q3 FY2026's INR 54 Cr revenue repeats |
| FY2027 audited results & cash flow | May 2027 | Return to positive CFO; borrowing trajectory |
| Other income composition | Ongoing | Recurring (rent/interest) vs one-off |
| Further promoter capital or asset monetisation | Unscheduled | Any sale/lease of hotel or farmland assets to deleverage |
| Export initiative | Unscheduled | First foreign-exchange earnings |
| Succession planning | Unscheduled | Clarity on leadership after the 75-year-old CMD |
| Contingent liabilities | Annual | Any crystallisation of the INR 17.5–19.9 Cr cited by data providers |
Analyst verdict
Ambica Agarbathies Aroma & Industries is a classic Indian micro-cap value trap candidate: a genuine heritage brand and a substantial block of hard assets wrapped in a balance sheet and governance structure that have prevented those assets from earning acceptable returns. The FY2026 numbers are the best in six years — revenue of INR 141 Cr, up 14%, and PAT of INR 3.45 Cr — and the agarbathi business demonstrably grew almost 20%. Yet the quality of those earnings is weak. Interest absorbed more than the entire operating profit, other income supplied the bulk of pre-tax profit, and operating cash flow turned negative as receivables swelled. Borrowings have climbed by a third in three years while equity has barely moved.
The bull thesis rests on asset value. The company trades at roughly 0.37x book and about 0.3x sales, with owned hotel properties in Chennai and Visakhapatnam and fixed assets exceeding equity. Promoters have just added capital at INR 25 per share. If management were to monetise non-core assets (film, wind, farmland, or even a hotel) and use proceeds to cut debt, the interest burden would ease sharply and reported earnings would rise disproportionately, likely narrowing the discount.
The bear thesis is that nothing in the disclosure record suggests such a catalyst is coming. There is no stated strategy, no guidance, no R&D, no investor communication, no analyst coverage and no succession plan for a 75-year-old CMD, and the family controls every executive seat. Without a change in capital allocation, the asset discount can persist indefinitely.
The decisive monitorables are a sustained return to positive operating cash flow, stabilisation of borrowings below INR 100 Cr, and any concrete asset-monetisation step. Absent these, the deep discount to book looks justified rather than anomalous.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | DIN | Tenure / appointment | Age | Background | Shares held (31 Mar 2026) |
|---|---|---|---|---|---|---|
Ambica Krishna (V.V.P. Krishna Rao Ambica Krishna) | Chairman & Managing Director | 00,391,898 | CMD since at least 2010-11; re-appointed 13 Feb 2026 to 12 Feb 2029 | 75+ (AR states he has attained 75) | 4+ decades in production, purchase and marketing | 13,91,806 |
Ambica Ramachandra Rao | Whole-time Director | 01,678,538 | First appointed 30 Nov 2001; re-appointed 2024; retires by rotation 2026, re-appointed | 55 (born 26 Feb 1971) | 20+ years in purchase and marketing of agarbathies; undergraduate | 6,16,950 |
Satyavathi Perla | Whole-time Director (woman director) | 07,141,289 | Re-appointed at 29th AGM (2024) | — | — | 1,39,989 |
Mallikarjunarao Voleti | Independent Director; Chair of Audit, NRC and SRC | — | — | — | — | 0 |
B V Subrahmanyeswarao | Independent Director | — | — | — | — | 0 |
Chunduru Anjaneya Swamy | Independent Director | 08,810,748 | Re-appointed at 30th AGM (26 Sep 2025) | — | — | 0 |
Alapati Hanuma (Ambica Hanuma) | Chief Financial Officer | — | — | — | Family member (per Sugandh India family list) | — |
Uma Gayathri | Company Secretary & Compliance Officer | — | — | — | — | — |
“—” = not publicly disclosed.
Directors' Remuneration
| Name | Salary & perks | Bonus | Stock | Total |
|---|---|---|---|---|
Ambica Krishna (CMD) | 1,200,000 | 0 | 0 | 1,200,000 |
Satyavathi Perla (WTD) | 1,200,000 | 0 | 0 | 1,200,000 |
Ambica Ramachandra Rao (WTD) | 0 | 0 | 0 | 0 |
Independent directors (each) | 0 | 0 | 0 | 0 |
Shareholding Trend
| Holder category | Dec 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
Promoters (%) | 44.86 | 43.69 | 43.41 | 43.41 | 43.41 | 46.08 |
FIIs (%) | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Public (%) | 55.14 | 56.29 | 56.58 | 56.58 | 56.57 | 53.91 |
Number of shareholders | 7,917 | 8,680 | 8,830 | 8,335 | 8,245 | 8,351 |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
26 Sep 2025 | Chunduru Anjaneya Swamy re-appointed Independent Director | Second term |
12 Feb 2026 | Ambica Krishna re-appointed CMD for 3 years from 13 Feb 2026 | Aged 75; special resolution required |
29 Sep 2026 | Ambica Ramachandra Rao re-appointed on rotation; CMD re-appointment ratified | All resolutions passed at 31st AGM |
Competitive Landscape
Key Competitors
| Competitor | Owner / listing | Flagship brand(s) | Relative positioning vs Ambica |
|---|---|---|---|
ITC Limited | Listed (NSE: ITC) | Mangaldeep | National leader; ITC stated (2020) Mangaldeep had ~10% share of a ~INR 8,800 Cr market — #1 in dhoop, #2 in agarbathi; vastly larger scale and distribution |
N. Ranga Rao & Sons Pvt Ltd | Private | Cycle Pure Agarbathies | National/global leader; strong South India overlap; exports widely |
Mysore Deep Perfumery House | Private | Zed Black | Major national player; investing in automation |
Moksh Agarbatti Co | Private | Moksh | National brand |
Hari Darshan Sevashram Pvt Ltd | Private | Hari Darshan | Strong in North/West India |
Patanjali Ayurved Ltd | Private | Patanjali Aastha | Herbal positioning; mass distribution |
Hem Corporation Pvt Ltd | Private | HEM | Export-led |
Shree Kalpana Perfumery Works | Private | Kalpana | Regional/national |
B.V. Aswathiah & Bros | Private | Nandi | Karnataka-based, South India overlap |
Godrej Consumer Products | Listed (NSE: GODREJCP) | Goodknight agarbatti (repellent, launched Feb 2024) | Adjacent repellent-incense format |
Kanpur Flowercycling Pvt Ltd | Private | Phool | Premium, recycled-flower incense |
Peer Comparison FY2026
| Metric | Ambica (FY2026) | ITC Mangaldeep |
|---|---|---|
Incense revenue | INR 115.8 Cr (segment turnover) | Not separately disclosed (ITC reports within "Other FMCG") |
Growth | +19.9% (agarbathi segment) | — |
Margins | Company EBITDA 7.2% | Not disclosed at brand level |
R&D intensity | 0% | Not disclosed at brand level |
Market share | ~1.3% (derived: INR 115.8 Cr ÷ INR 8,800 Cr) | ~10% (ITC, 2020) |
“—” = not publicly disclosed.



